# The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis

> **NCT05235711** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 87 (actual)

## Conditions studied

- Fungal Infection
- Candidiasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05235711
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-10
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-08-31
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05235711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05235711, "The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05235711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*